Trafalgar International, Inc.
GCAND- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001695473
No open-market purchases or sales by Trafalgar International, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesGCAN
13F holders, Q2 2026
Institutional positions in Trafalgar International, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 0
- 0 vs. Q1 2026
- Shares held
- 0
- 0 vs. Q1 2026
- Total value
- $0
- $0 vs. Q1 2026
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Trafalgar International, Inc.; share changes are against Q1 2026.
No institution reported holding GCAND in Q2 2026.